The American Medical Women’s Association (AMWA), Global Initiative Against HPV and Cervical Cancer (GIAHC), and Indiana University National Center of Excellence in Women’s Health (IUNCoE) are proud to host the 2021 Us vs. HPV webinar series. Topics include FDA’s approval of the HPV vaccine for oropharyngeal cancer, WHO’s formal adoption of the global strategy to eliminate cervical cancer, and more.
Cervical cancer is caused by a virus called the human papillomavirus, or HPV. It is completely preventable by safe, simple and inexpensive methods, yet it is a leading cause of death among women around the world.
Lack of awareness that cervical cancer is a preventable public health problem is the main causes of high rates of this disease.
With proper education, regular screening and vaccination, cervical cancer is almost completely preventable.
Sign up to become a GIAHC champion to receive periodic email updates on our work as well as news in the field of cervical cancer prevention.
Your generosity makes our work to empower people, communities and societies to fight against cervical cancer possible.
Saving lives from cervical cancer, one woman at a time, one day at a time.
For women to live in a cervical cancer-free world by embracing the power of collective engagement.
No woman deserves to die of cervical cancer. Cervical cancer is a preventable public health disease that can almost be eradicated through vaccination, screening and early treatment programs.
Prarthana is a global health scientist and practitioner, passionate about translating evidence for decision-making and policy. For the past five years, she has specialized in vaccine communications and advocacy. She currently works at the Johns Hopkins International Vaccine Access Center (IVAC) on various policy and advocacy projects. Prior to public health, she worked for five years in academia conducting microbiology and immunology laboratory research. She received her Master of Science (MS) in Biological Sciences from the University of Maryland and her Master of Science in Public Health (MSPH) in Global Disease Epidemiology & Control from the Johns Hopkins Bloomberg School of Public Health, where she also earned a Certificate in Vaccine Science & Policy. With GIAHC, Prarthana leads a team of young members to develop and maintain technical content, as well as provides strategic advocacy and communications input on GIAHC projects.